The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...

The British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.

T cells are crucial components of our immune system, serving as critical protectors against infection and disease. But there ...

Pre-wired ability in ‘resting’ T cells to remember past viral foes discovered, a promising breakthrough for targeted cancer therapies. A team of immunologists at the University of Massachusetts ...

T cells, which target infection and disease, can become more effective after a meal. The finding might help improve ...

We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease ...

This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...